Committee approves sickle‑cell continuing education requirement after emotional testimony from patients and caregivers

CS for HB 353, carried by Representative Robinson, passed the Health & Human Services Committee after testimony from patients, caregivers and advocacy groups describing barriers to appropriate care for people with sickle cell disease.

Sponsor testimony framed the bill as a practical step to include sickle‑cell education and pain‑management training in existing continuing education for medical professionals. Advocates and patients described repeated experiences of being disbelieved, delayed treatment and inadequate pain control in emergency and specialty settings.

Maya Thomas, a patient living with sickle cell, said she was diagnosed at birth and urged lawmakers to pass the bill so clinicians would better understand individualized care. Other speakers, including caregivers and nonprofit advocates, cited CDC prevalence estimates and called for action to reduce hospitalizations and improve long‑term outcomes.

The committee voted to report CS for HB 353 favorably (roll‑call: 23 ayes, 0 nays). Sponsors and supporters said the requirement is educational rather than punitive and will be implemented through existing continuing‑education channels for clinicians.

Actions taken in committee were limited to reporting the bill favorably; details of continuing-education content and implementation will be worked out with professional boards and licensing authorities if the bill advances.